Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting neuroinflammation in Alzheimer’s disease
Maria Rosanna Bronzuoli, Aniello Iacomino, Luca Steardo, et al.
Journal of Inflammation Research (2016) Vol. Volume 9, pp. 199-208
Open Access | Times Cited: 217

Showing 1-25 of 217 citing articles:

The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review
Marta Sochocka, Katarzyna Donskow‐Łysoniewska, Breno S. Diniz, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 3, pp. 1841-1851
Open Access | Times Cited: 497
Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment
Ravinder Nagpal, Bryan J. Neth, Shaohua Wang, et al.
EBioMedicine (2019) Vol. 47, pp. 529-542
Open Access | Times Cited: 484
Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective
Rodrigo E. González-Reyes, Mauricio O. Nava-Mesa, Karina Vargas-Sánchez, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 453
Current state of Alzheimer’s fluid biomarkers
José Luís Molinuevo, Scott Ayton, Richard Batrla, et al.
Acta Neuropathologica (2018) Vol. 136, Iss. 6, pp. 821-853
Open Access | Times Cited: 445
Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration
Duraisamy Kempuraj, Ramasamy Thangavel, Govindhasamy Pushpavathi Selvakumar, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 315
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease
Rishika Dhapola, Subhendu Shekhar Hota, Phulen Sarma, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 6, pp. 1669-1681
Open Access | Times Cited: 240
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
Karen Wagner, Cindy B. McReynolds, W. Schmidt, et al.
Pharmacology & Therapeutics (2017) Vol. 180, pp. 62-76
Open Access | Times Cited: 235
Forsythoside A Mitigates Alzheimer's-like Pathology by Inhibiting Ferroptosis-mediated Neuroinflammation via Nrf2/GPX4 Axis Activation
Chunyue Wang, Shanshan Chen, Hangyu Guo, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 5, pp. 2075-2090
Open Access | Times Cited: 187
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Dawling A. Dionisio-Santos, John A. Olschowka, M. Kerry O’Banion
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 150
Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study
Ravinder Nagpal, Bryan J. Neth, Shaohua Wang, et al.
EBioMedicine (2020) Vol. 59, pp. 102950-102950
Open Access | Times Cited: 140
The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota
Friedrich Leblhuber, Daniela Ehrlich, Kostja Steiner, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 361-361
Open Access | Times Cited: 109
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Donovan McGrowder, Fabian Miller, Kurt Vaz, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 215-215
Open Access | Times Cited: 108
Neuroinflammation: A Potential Risk for Dementia
Md Afroz Ahmad, Ozaifa Kareem, Mohammad Khushtar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 616-616
Open Access | Times Cited: 90
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 78
Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study
Hana Florian, Deli Wang, Steven E. Arnold, et al.
Brain (2023) Vol. 146, Iss. 6, pp. 2275-2284
Open Access | Times Cited: 64
Nitric Oxide/Nitric Oxide Synthase System in the Pathogenesis of Neurodegenerative Disorders—An Overview
Olga-Maria Iova, Gheorghe-Eduard Marin, Izabella Lazar, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 753-753
Open Access | Times Cited: 53
Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
Mohammed Alsubaie, Suhuai Luo, Kamran Shaukat
Machine Learning and Knowledge Extraction (2024) Vol. 6, Iss. 1, pp. 464-505
Open Access | Times Cited: 34
Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)
Pei Qin, Ye Sun, Liya Li
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 5
Open Access | Times Cited: 16
Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer’s disease: Rational insights for the therapeutic approaches
Mir Hilal Ahmad, Mahino Fatima, Amal Chandra Mondal
Journal of Clinical Neuroscience (2018) Vol. 59, pp. 6-11
Closed Access | Times Cited: 153
Neuroprotective effect of berberine against environmental heavy metals-induced neurotoxicity and Alzheimer's-like disease in rats
Hend M. Hussien, Aml Abd-Elmegied, Doaa A. Ghareeb, et al.
Food and Chemical Toxicology (2017) Vol. 111, pp. 432-444
Closed Access | Times Cited: 146
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease
Niraj Kumar Jha, Saurabh Kumar Jha, Rohan Kar, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 2, pp. 113-137
Open Access | Times Cited: 135
Glia Crosstalk in Neuroinflammatory Diseases
Ada Bernaus, Sandra Blanco, Ana Sevilla
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 124
Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model
Mudan Cai, Jun‐Hwan Lee, Eun Jin Yang
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 121
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
Gemma Navarro, Dasiel O. Borroto‐Escuela, Edgar Angelats, et al.
Brain Behavior and Immunity (2017) Vol. 67, pp. 139-151
Closed Access | Times Cited: 104
Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism
Fawaz Alasmari, Musaad A. Alshammari, Abdullah F. Alasmari, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-8
Open Access | Times Cited: 104
Page 1 - Next Page

Scroll to top